Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, Boyle J, Teede HJ. Polycystic ovary syndrome. Lancet Diab Endocrinol. 2022;10(9):668–80.

Article  CAS  Google Scholar 

Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237–45.

Article  PubMed  CAS  Google Scholar 

Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2004;82(3):661–5.

Article  PubMed  Google Scholar 

DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83(5):1454–60.

Article  PubMed  CAS  Google Scholar 

Naderpoor N, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ. Obesity and polycystic ovary syndrome. Minerva Endocrinol. 2015;40(1):37–51.

PubMed  CAS  Google Scholar 

Wu S, Divall S, Nwaopara A, Radovick S, Wondisford F, Ko C, Wolfe A. Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell. Diabetes. 2014;63(4):1270–82.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 2. Endocr Pract. 2015;21(12):1415–26.

Article  PubMed  Google Scholar 

Coutinho EA, Kauffman AS. The role of the brain in the pathogenesis and physiology of Polycystic Ovary Syndrome (PCOS). Med Sci (Basel). 2019;7(8):84.

PubMed  CAS  Google Scholar 

Polak K, Czyzyk A, Simoncini T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest. 2017;40(1):1–8.

Article  PubMed  CAS  Google Scholar 

Zhang S, Tu H, Zhu J, Liang A, Huo P, Shan K, He J, Zhao M, Chen X, Lei X. Dendrobium nobile Lindl. polysaccharides improve follicular development in PCOS rats. Int J Biol Macromol. 2020;149:826–34.

Article  PubMed  CAS  Google Scholar 

Zhang Y, Liu L, Yin T-L, Yang J, Xiong C-L. Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients. Oncotarget. 2017;8(46):80472–80.

Article  PubMed  PubMed Central  Google Scholar 

Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health (Larchmt). 2015;24(4):299–307.

Article  PubMed  Google Scholar 

Yao X, Li F, Wei Z, Ei-Samahy MA, Feng X, Yang F, Wang F. Integrative genome-wide DNA methylome and transcriptome analysis of ovaries from Hu Sheep with high and low prolific. Front Cell Dev Biol. 2022;10:820558.

Article  PubMed  PubMed Central  Google Scholar 

Weng Y, Zhang Y, Wang D, Wang R, Xiang Z, Shen S, Wang H, Wu X, Wen Y, Wang Y. Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1α-TXNIP/ROS-NLRP3 pathway in PCOS. J Ovarian Res. 2023;16(1):151.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–84.

Article  PubMed  Google Scholar 

Wang C, Ding C, Hua Z, Chen C, Yu J. Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway. Mediators Inflamm. 2020;2020:8865647.

Article  PubMed  PubMed Central  Google Scholar 

Wieser V, Moschen AR, Tilg H. Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp (Warsz). 2013;61(2):119–25.

Article  PubMed  CAS  Google Scholar 

Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(3):1048-58.e1-2.

Article  PubMed  CAS  Google Scholar 

Yang Z, Fu H, Su H, Cai X, Wang Y, Hong Y, Hu J, Xie Z, Wang X. Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome. Front Microbiol. 2022;13:1017147.

Article  PubMed  PubMed Central  Google Scholar 

Cirillo F, Catellani C, Lazzeroni P, Sartori C, Nicoli A, Amarri S, La Sala GB, Street ME. MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity. Front Endocrinol (Lausanne). 2019;10:879.

Article  PubMed  Google Scholar 

González F. Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300–5.

Article  PubMed  Google Scholar 

González F, Rote NS, Minium J, Kirwan JP. Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(4):1508–12.

Article  PubMed  Google Scholar 

Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2011;335(1):30–41.

Article  PubMed  CAS  Google Scholar 

Robker RL, Wu LLY, Yang X. Inflammatory pathways linking obesity and ovarian dysfunction. J Reprod Immunol. 2011;88(2):142–8.

Article  PubMed  CAS  Google Scholar 

Hsu S-K, Li C-Y, Lin IL, Syue W-J, Chen Y-F, Cheng K-C, Teng Y-N, Lin Y-H, Yen C-H, Chiu C-C. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics. 2021;11(18):8813–35.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660–5.

Article  PubMed  CAS  Google Scholar 

Sborgi L, Rühl S, Mulvihill E, Pipercevic J, Heilig R, Stahlberg H, Farady CJ, Müller DJ, Broz P, Hiller S. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 2016;35(16):1766–78.

Article  PubMed  PubMed Central  CAS  Google Scholar 

McKenzie BA, Dixit VM, Power C. Fiery Cell Death: Pyroptosis in the Central Nervous System. Trends Neurosci. 2020;43(1):55–73.

Article  PubMed  CAS  Google Scholar 

Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–20.

Article  PubMed  CAS  Google Scholar 

Zhang Y, Xie X, Ma Y, Du C, Jiao Y, Xia G, Xu J, Yang Y. Cyproterone acetate mediates IRE1α signaling pathway to alleviate pyroptosis of ovarian granulosa cells induced by hyperandrogen. Biology. 2022;11(12):1761.

Article